Lucentis® (ranibizumab) is the first licensed therapy to improve vision in patients with visual impairment due to choroidal neovascularization secondary to…
18-4-2013 — /europawire.eu/ — The new Collective Labour Agreement is expected to go into effect on 1 July 2013. The main…